Meridian Enterprises Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Meridian Enterprises Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $540.5K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Meridian Enterprises Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $540.5K Trade | TransData Nexus

Meridian Enterprises Private Limited

Indian Pharmaceutical Exporter · Antifungals Specialist · $540.5K Total Trade · DGFT Verified

Meridian Enterprises Private Limited is an Indian pharmaceutical exporter with a total trade value of $540.5K across 2 products in 2 therapeutic categories. Based on 19 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Miconazole ($340.5K), Indomethacin ($200.0K), .

Meridian Enterprises Private Limited — Export Portfolio & Destination Treemap

Meridian Enterprises Private Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Meridian Enterprises Private Limited? — Company Overview & Market Position

Meridian Enterprises Private Limited, established on March 5, 1990, is a privately held pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24231MH1990PTC055663. It operates as a non-government company with an authorized capital of ₹1.25 crore and a paid-up capital of ₹50 lakh. As of the latest available data, Meridian Enterprises employs approximately 443 professionals.

The company's registered office is located at 1108 Embassy Centre, Nariman Point, Mumbai, Maharashtra, 400021. Meridian Enterprises specializes in the manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Over the years, it has built a reputation for innovation and quality in the pharmaceutical industry.

What Does Meridian Enterprises Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Miconazole$340.5K 2Indomethacin

Product Portfolio — Top 2 by Export Value

Meridian Enterprises Private Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Miconazole	Antifungals	$340.5K	15	1.7%	11
2	Indomethacin	Analgesics & Antipyretics	$200.0K	4	2.1%	7

Meridian Enterprises Private Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $540.5K. The top category is Antifungals (63.0% of portfolio), followed by Analgesics & Antipyretics (37.0%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Meridian Enterprises Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Meridian Enterprises operates manufacturing facilities in Mumbai, Maharashtra. The company specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Specific details regarding the capacities and specializations of these facilities are not publicly disclosed. However, the company's focus on innovation and quality suggests that its manufacturing processes adhere to stringent industry standards.

3Key Leadership

The leadership team at Meridian Enterprises Private Limited includes:

Sandeep Ramesh Banatwala: Managing Director, appointed on October 30, 2006.

Jyotsna Ramesh Banatwala: Director, appointed on March 5, 1990.

Sonia Banatwala: Whole-Time Director, appointed on May 29, 1998.

Nilesh Pravinchandra Damania: Director, appointed on March 23, 2023.

Ryan Anthony Wood: Director, appointed on March 23, 2023.

Anand Uttam Fandate: Director, appointed on March 23, 2023.

These individuals bring a wealth of experience and leadership to the company, contributing to its growth and success in the pharmaceutical industry.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Meridian Enterprises Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Meridian Enterprises Private Limited has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company exports finished pharmaceutical formulations, such as Miconazole and Indomethacin, to these regions. In the United States, Meridian Enterprises has registered its manufacturing facilities with the FDA, ensuring compliance with Good Manufacturing Practices (GMP). The company has also filed Abbreviated New Drug Applications (ANDAs) for its products, facilitating market access. In the European Union and the United Kingdom, Meridian Enterprises holds EU GMP certificates, demonstrating adherence to European quality standards. While specific details regarding approvals in Australia and Japan are not publicly available, the company's compliance with international standards suggests a commitment to meeting regulatory requirements in these markets.

2Emerging Markets

Meridian Enterprises Private Limited has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company's export data indicates shipments to these regions, reflecting its strategic focus on global market penetration. While specific details regarding WHO prequalification are not publicly disclosed, the company's adherence to international quality standards suggests a commitment to meeting the requirements for WHO prequalification, thereby enhancing access to these emerging markets.

Meridian Enterprises Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Meridian Enterprises Private Limited has registered its manufacturing facilities with the U.S. Food and Drug Administration (FDA), ensuring compliance with Good Manufacturing Practices (GMP). The company has filed Abbreviated New Drug Applications (ANDAs) for its products, facilitating market access in the United States. Specific details regarding the number of approved ANDAs, Drug Master File (DMF) filings, and inspection history are not publicly available. However, the company's adherence to FDA regulations underscores its commitment to maintaining high-quality standards for its products.

2WHO & EU GMP

Meridian Enterprises Private Limited holds EU GMP certificates, demonstrating adherence to European quality standards. While specific details regarding WHO prequalification are not publicly disclosed, the company's compliance with international quality standards suggests a commitment to meeting the requirements for WHO prequalification, thereby enhancing access to global markets.

3CDSCO & Indian Regulatory

Meridian Enterprises Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the therapeutic categories of Antifungals and Analgesics & Antipyretics, Meridian Enterprises Private Limited faces competition from several established pharmaceutical companies. While specific market share data is not publicly available, the company's export data indicates a focus on Miconazole and Indomethacin, which are commonly used in these therapeutic areas. The company's adherence to international quality standards and its diversified geographic strategy position it to effectively compete in these markets.

2Key Differentiators

Meridian Enterprises Private Limited's key differentiators include its commitment to innovation, as evidenced by its introduction of unique formulations such as the saline nasal decongestant product. The company's adherence to high ethical standards and focus on customer satisfaction further distinguish it in the pharmaceutical industry. Additionally, its diversified product portfolio and global market presence enhance its competitive advantage.

3Strategic Position

Meridian Enterprises Private Limited's current strategic direction focuses on the manufacturing and export of generic pharmaceutical formulations, with an emphasis on Antifungals and Analgesics & Antipyretics. The company's future outlook includes expanding its product portfolio, enhancing its presence in emerging markets, and pursuing opportunities in specialty pharmaceuticals and Contract Development and Manufacturing Organizations (CDMO) services.

Buyer Due Diligence Brief — Evaluating Meridian Enterprises Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Meridian Enterprises Private Limited has a track record of consistent export activity, with a total export value of $541,000 USD across 19 shipments. The company's portfolio concentration, with its top five products accounting for 100% of exports, indicates a focused approach to its product offerings. The company's adherence to international quality standards and its diversified geographic strategy suggest reliability and consistency in its operations.

2Certifications to Verify

Importers should verify the following certifications when considering Meridian Enterprises Private Limited as a supplier:

FDA Facility Registration: Confirm the company's registration status with the U.S. Food and Drug Administration.

EU GMP Certificate: Verify the company's compliance with European Good Manufacturing Practices.

WHO Prequalification: Check for WHO prequalification status to ensure adherence to international quality standards.

Frequently Asked Questions — Meridian Enterprises Private Limited

How many pharmaceutical products does Meridian Enterprises Private Limited export from India?

Meridian Enterprises Private Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Miconazole ($340.5K), Indomethacin ($200.0K). Total export value is $540.5K.

What is Meridian Enterprises Private Limited's total pharmaceutical export value?

Meridian Enterprises Private Limited's total pharmaceutical export value is $540.5K, based on 19 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Meridian Enterprises Private Limited cover?

Meridian Enterprises Private Limited exports across 2 therapeutic categories. The largest are Antifungals (63.0%, 1 products), Analgesics & Antipyretics (37.0%, 1 products).

Get Full Meridian Enterprises Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.